Literature DB >> 4303649

Pseudomonas aeruginosa keratitis: mixed infections of the eye.

R P Burns.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4303649     DOI: 10.1016/0002-9394(69)93156-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  8 in total

1.  Nebcin in the treatment of experimental Pseudomonas keratitis.

Authors:  R Belfort; G Smolin; M Okumoto; H B Kim
Journal:  Br J Ophthalmol       Date:  1975-12       Impact factor: 4.638

Review 2.  Experimental Pseudomonas keratitis.

Authors:  R A Hyndiuk
Journal:  Trans Am Ophthalmol Soc       Date:  1981

3.  Suppurative corneal ulceration following herpetic keratitis.

Authors:  K R Wilhelmus
Journal:  Doc Ophthalmol       Date:  1982-05-14       Impact factor: 2.379

4.  The cif Virulence Factor Gene Is Present in Isolates From Patients With Pseudomonas aeruginosa Keratitis.

Authors:  Christopher D Bahl; Jessica D St Laurent; R Siva Ganesa Karthikeyan; J Lakshmi Priya; Lalitha Prajna; Michael E Zegans; Dean R Madden
Journal:  Cornea       Date:  2017-03       Impact factor: 2.651

5.  Topical steroids in the treatment of central and paracentral corneal ulcers.

Authors:  T R Carmichael; Y Gelfand; N H Welsh
Journal:  Br J Ophthalmol       Date:  1990-09       Impact factor: 4.638

6.  Changing trends in the clinical course and outcome of bacterial keratitis at King Khaled Eye Specialist Hospital.

Authors:  Ali Al-Shehri; Sabah Jastaneiah; Michael D Wagoner
Journal:  Int Ophthalmol       Date:  2008-04-03       Impact factor: 2.031

7.  Topical immunotherapy for pseudomonas keratitis in rabbits: use of antilipopolysaccharide plasma.

Authors:  N H Welsh; A J Rauch; S L Gaffin
Journal:  Br J Ophthalmol       Date:  1984-11       Impact factor: 4.638

8.  Pseudomonas aeruginosa: isolation from ocular tissues. Aeruginocin typing and its relationship to corneal pathogenicity in rabbits.

Authors:  V M Mahajan; T A Srikanth; L P Agarwal
Journal:  Int Ophthalmol       Date:  1982-02       Impact factor: 2.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.